Scientists find DNA repair ’scissors’ after 18 year hunt
Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC). The program provides strong evidence that Alpharadin can prolong patient survival times, improve quality of
Full Post: Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer
Cancer Research UK scientists have identified a long sought after enzyme that plays a critical role in a DNA repair pathway linked with inheritable breast and ovarian cancer, reveals research published in Nature.
Familial breast cancers, such as those caused by mutation of the BRCA2 tumour suppressor, are caused by defects in a pathway that rejoins breaks in the DNA.
After an 18-year search, scientists have found a new factor - known as GEN1 - that plays a crucial role in this pathway, and it is likely that this factor may be important for preventing cancer.
This finding expands our understanding of how inheritable breast cancers develop and it is possible that mutations in GEN1 may also be linked with other types of cancer.
Professor Stephen West, based at Cancer Research UK’s Clare Hall laboratories, part of the London Research Institute, said: “This is an important enzyme that plays a key role in cellular reactions that repair damaged DNA. Our finding that this enzyme acts in the same pathway as BRCA2 suggests that it is going to be important for cancer prevention.”
Breaks in DNA are repaired by a process known as recombinational repair, which is regulated by BRCA2. During this process, the broken DNA joins with a DNA template to form a four-way DNA junction.
The GEN1 enzyme found in this study acts as a pair of ’scissors’ that cuts the four-way junction - a reaction that is essential for forming normal DNA. Loss of this enzyme is thought to lead to genetic damage that can result in cancerous tumours forming.
It is hoped that this discovery will enable scientists to find other genes involved in this repair process that, when damaged or mutated, cause cancer.
Professor West continued: “This discovery adds another piece in the puzzle to improve our understanding of the molecular processes that can lead to cancer. Future studies of GEN1 will provide new insights into these reactions, and provide a more complete picture of the steps that lead to the disease.”
Dr Lesley Walker, director of cancer information at Cancer Research UK, said: “Knowing that this enzyme is important for DNA repair is an important step forward in cancer research. Most cancer genes are identified by studying the genetic profile of people affected by the disease. This discovery will allow us to work from the bottom up - genes such as GEN1 will almost certainly determine your risk of cancer.
Breast cancer, the leading cause of death among women in France, is the most commonly occurring cancer in women. Sporadic breast cancer, which is non-hereditary, turns out to be the most widespread, representing 85 to 90% of all cases, but remains the least well-known. Researchers at CNRS and CEA, working with a team from H?al
Full Post: Does hormone treatment predispose patients to breast cancer?
A baby girl about to be born in Britain will be the first to have been screened for a breast cancer causing gene. The baby’s mother, is due to give birth soon to the first British baby to have been screened to be free of a gene which can cause breast cancer. The baby’s parents
Full Post: Baby girl due soon will be minus breast cancer causing gene
Canadian researchers have identified a new protein in the progression of breast cancer. According to a recent study from the Université de Montréal and the University of Alberta, published in the Journal of Biological Chemistry, the protein ARF1 plays a critical role in cancer cell growth and the spread of tumours. Targeting this protein with
Full Post: Discovery of new protein that triggers breast cancer
Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN ). The pathway is involved in angiogenesis, cell growth, differentiation, and survival. In addition, it is part of the PI3/AKT/mTOR pathway, which plays
Full Post: Researchers focus on phosphoinositide 3-kinase pathway in cancer research
Metastasis is the ability of cancer cells to spread from a primary site, to form tumours at distant sites. It is a complex process in which cell motility and invasion play a fundamental role. Essential to our understanding of how metastasis develops is identification of the molecules, and characterisation of the mechanisms that regulate cell
Full Post: Exciting cancer discovery